These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7934355)
21. New Vaccines for the World's Poorest People. Hotez PJ; Bottazzi ME; Strych U Annu Rev Med; 2016; 67():405-17. PubMed ID: 26356803 [TBL] [Abstract][Full Text] [Related]
22. Anti-parasite vaccines. McLaren DJ; Terry RJ Trans R Soc Trop Med Hyg; 1989; 83(2):145-6, 178. PubMed ID: 2692216 [No Abstract] [Full Text] [Related]
23. [Immunization against protozoal diseases]. Neal RA; Garnham PC; Cohen S Bol Oficina Sanit Panam; 1973 Oct; 75(4):337-53. PubMed ID: 4272727 [No Abstract] [Full Text] [Related]
24. Current strategies for drug development against major human parasites: malaria and schistosomiasis. Khalife J Curr Pharm Des; 2012; 18(24):3453. PubMed ID: 22721585 [No Abstract] [Full Text] [Related]
25. Health advice for travelers to Latin America. Istúriz RE; Stamboulian D; Lepetic A; Mondolfi A Infect Dis Clin North Am; 1994 Mar; 8(1):155-81. PubMed ID: 8021443 [TBL] [Abstract][Full Text] [Related]
26. [DNA immunization and its application in the field of parasitology]. Chen Z; Guan W; Zhang L Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998; 16(2):133-7. PubMed ID: 12078224 [No Abstract] [Full Text] [Related]
27. Progress on vaccines against parasites. Engers HD; Bergquist R; Modabber F Dev Biol Stand; 1996; 87():73-84. PubMed ID: 8854004 [TBL] [Abstract][Full Text] [Related]
28. Can molecular biology synthesise a vaccine to eradicate both malaria and bilharzia? If so, should a developing country like Zimbabwe become involved in their development? Robertson AI Cent Afr J Med; 1985 Nov; 31(11):231-4. PubMed ID: 3938343 [No Abstract] [Full Text] [Related]
31. The variation of antigen expression: a natural phenomenon utilised for the construction of live recombinant Salmonella vaccines. Yan ZX; Meyer TF Behring Inst Mitt; 1994 Dec; (95):49-56. PubMed ID: 7755509 [No Abstract] [Full Text] [Related]
32. [Use of Salmonellas as a vector in the designing of recombinant vaccines]. Boĭchenko MN; Vorobév AA Vestn Ross Akad Med Nauk; 1997; (3):43-6. PubMed ID: 9181857 [No Abstract] [Full Text] [Related]
33. Recombinant-attenuated Ding K; Shang K; Yu ZH; Yu C; Jia YY; He L; Liao CS; Li J; Zhang CJ; Li YJ; Wu TC; Cheng XC J Vet Sci; 2018 Mar; 19(2):232-241. PubMed ID: 29032660 [TBL] [Abstract][Full Text] [Related]
34. Optimal control analysis of malaria-schistosomiasis co-infection dynamics. Okosun KO; Smith R Math Biosci Eng; 2017 Apr; 14(2):377-405. PubMed ID: 27879105 [TBL] [Abstract][Full Text] [Related]
35. Salmonellae as oral vaccine carriers. Schödel F; Curtiss R Dev Biol Stand; 1995; 84():245-53. PubMed ID: 7796961 [No Abstract] [Full Text] [Related]
37. An experiment in the control of malaria and bilharziasis. ALVES W; BLAIR DM Trans R Soc Trop Med Hyg; 1953 Jul; 47(4):299-308. PubMed ID: 13090289 [No Abstract] [Full Text] [Related]
38. [Challenge and strategy of prevention and control of important parasitic diseases under the Belt and Road Initiative]. Chun-Li C; Jia-Gang G Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2018 Apr; 30(2):111-116. PubMed ID: 29770648 [TBL] [Abstract][Full Text] [Related]
39. The development of oral vaccines based on live attenuated Salmonella strains. Chatfield S; Roberts M; Londono P; Cropley I; Douce G; Dougan G FEMS Immunol Med Microbiol; 1993 Jun; 7(1):1-7. PubMed ID: 8364518 [TBL] [Abstract][Full Text] [Related]